48194-Lim, Kenneth

Kenneth Lim, MD, PhD

Assistant Professor of Medicine

Email kjlim@iu.edu
R2 202
Indianapolis, IN


Ken Lim, M.D., Ph.D., M.Phil., F.A.S.N. is an American Physician-Scientist and Nephrologist in the Division of Nephrology & Hypertension at Indiana University School of Medicine (IUSM). Prior to joining the faculty at IUSM in 2020, he spent over 10 years at Harvard Medical School and affiliated major teaching hospitals, later becoming Attending Physician at The Massachusetts General Hospital and a faculty member at Harvard Medical School. He is a graduate of The University of Cambridge (Christ’s College) and The University of Warwick in England.

Dr. Lim is a Clinical and Translational Scientist and leads a research group that focuses on the development and delivery of definitive trials in the area of cardiovascular disease in patients with kidney failure, and the development of advanced therapeutics.
A major theme of his research group is the introduction of Cardiopulmonary Exercise Testing (CPET) into the field of cardio-nephrology, and to create advanced peptide therapeutics inspired by nature. A vision of his group is to be a strategic launching pad for next generation innovators, bioinspirationalists and clinical researchers who are global thinkers at the forefront of expanding the boundaries of this exciting field. Dr. Lim has a special interest in bioinnovation, healthcare  entrepreneurship, and translational strategies for taking biological discoveries into early phase exploratory trials. 

In his clinical role, he maintains an active clinical practice. He has deployed to regions around the world to provide leading medical care and strategic principles to help meet critical needs of victims of humanitarian crises, such as war, poverty and natural disasters.

Contact email: kjlim@iu.edu

Titles & Appointments

  • Assistant Professor of Medicine
  • Attending Physician | Indiana University Health
  • Principal Investigator | The Lim Laboratory
  • Education
    2018 FEL Massachusetts General Hospital
    2018 FEL Harvard Medical School
    2018 FEL Brigham and Women's Hospital
    2018 MSC University of Cambridge, England
    2015 RES Oregon Health & Science University
    2012 PhD University of Warwick, England
    2008 MD University of Warwick, England
    2004 BSC Coventry University, England
  • Research

    The mission of The Lim Laboratory is to help deliver definitive trials in the area of cardiovascular disease in patients with kidney failure, and to be an incubator for the development of advanced therapeutics. We integrate multidisciplinary approaches at the interface of translational and clinical research for improved patient care. 

    Our primary R&D platform focuses on therapeutic strategies for targeting cardiovascular disease in kidney failure, a current global health crisis. This capitalizes on our platform technologies, and translational & commercialization strategies in our group that accelerate entry of biological discoveries into early phase trials. We have an emphasis on multidisciplinary collaborations with projects that draw from an international talent pool. The process of innovation leverages on our relationships and networks with industry and beyond.


    One of the major platform technologies in our clinical research lab focuses on the use of state-of-the-art Cardiopulmonary Exercise Testing (CPET) technology, a robust and powerful technology that can accurately and reproducibly assess cardiovascular functional capacity. We are at the forefront of efforts to introduce CPET technology into the field of nephrology. The potential exists for CPET indices such as VO2Peak to be used as a new endpoint for cardiovascular trials in nephrology which can help overcome current challenges in cardio-renal trials methodologies. The technology has the potential to help move the cardio-renal field forward.


    Our wet lab specializes in translational research that focuses on the discovery and development of peptide therapeutics for cardiac disorders in kidney failure and beyond. We lead several exciting translational research studies using multidisciplinary approaches in cell and molecular biology, bioengineering and human tissue research. We take the approach of integrating our translational wet lab and clinical research efforts, and this stimulates multi-disciplinary collaboration on projects that support each other.

  • Professional Organizations
    American Heart Association
    American Society of Nephrology
    International Society of Nephrology
  • Board Certifications
    American Board of Internal Medicine - Internal Medicine
  • Clinical Interests
    Cardiorenal Syndrome
    Chronic Kidney Disease (CKD)
    End-Stage Kidney Disease (ESKD)
    Disaster Medicine/Nephrology 

Looking for patient care?

To schedule an appointment with a faculty member physician of IU School of Medicine, contact Indiana University Health at 888-484-3258 or use the physician finder by clicking the button below.

Find a doctor